The COVID-19 pandemic has created an “unprecedented visibility of regulatory services” among the general public, according to the European Medicines Agency’s executive director Emer Cooke. “People want to know what we’re doing,” she explained, especially when it came to authorizing vaccines and treatments for the coronavirus.
Opening the second day of AESGP’s 57th Annual Meeting, Cooke said there was an “increasing appetite for instant information, which is difficult to manage when you’re trying
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?